Botox is a multi-billion dollar, potentially deadly monopoly

The product comes from a substance so lethal that it could be used as a potential agent of bioterrorism.
Andreas Rentz/Getty Images

Pharma: an industry shaped by shareholder value

Jun 15, 2016
Big drug companies today have remade their business models.
Big Pharma has remade their business models over time to maximize shareholder value. 
Joe Raedle/Getty Images

The only way to stop inversions might be tax reform

Apr 6, 2016
The Pfizer-Allergan merger is out, but what about inversions across the board?
Pfizer was set to merge with Allergan, but after new inversion rules announced by the Treasury Department, the phama giants decided against merging. 
Spencer Platt/Getty Images

Pfizer's tax-driven Allergan merger

Nov 23, 2015
Regulators want to cut down on these deals, but this one is full-speed ahead.

Pfizer and Allergan agree to $160 billion "inversion"

Nov 23, 2015
The deal would create the largest pharmaceutical company in the world.

Activist investors help shareholders, right?

Apr 22, 2014
A new study says activist investors generated 48 percent average gain for companies they targeted.

For public good, not for profit.

Botox might help migraines

Sep 12, 2008
Botox eases wrinkles, but can it also ease migraine headaches? Allergan says it can. The company that produces Botox reports that two large tests...